Andreessen Horowitz, a Menlo Park, CA-based venture capital firm, has launched its $450m second bio fund.
Bio Fund II will focus on investing in companies at the intersection of biology and engineering.
SUBSCRIBE
Biohealth Innovation
Founding Member of
